Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse
- PMID: 12086936
- DOI: 10.2337/diabetes.51.7.2082
Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse
Abstract
Advanced glycation end products (AGEs), known promoters of diabetic complications, form abundantly in heated foods and are ingested in bioreactive forms. To test whether dietary AGEs play a role in the progression of insulin resistance, C57/BL/KsJ db/db mice were randomly placed for 20 weeks on a diet with either a low AGE content (LAD) or a 3.4-fold higher content of AGE (high AGE diet [HAD]), including (epsilon)N-carboxymethyllysine (CML) and methylglyoxal (MG). LAD-fed mice showed lower fasting plasma insulin levels throughout the study (P = 0.01). Body weight was reduced by approximately 13% compared with HAD-fed mice (P = 0.04) despite equal food intake. LAD-fed mice exhibited significantly improved responses to both glucose (at 40 min, P = 0.003) and insulin (at 60 min, P = 0.007) tolerance tests, which correlated with a twofold higher glucose uptake by adipose tissue (P = 0.02). Compared with the severe hypertrophy and morphological disorganization of islets from HAD-fed mice, LAD-fed mice presented a better-preserved structure of the islets. LAD-fed mice demonstrated significantly increased plasma HDL concentrations (P < 0.0001). Consistent with these observations, LAD-fed mice exhibited twofold lower serum CML and MG concentrations compared with HAD-fed mice (P = 0.02). These results demonstrate that reduced AGE intake leads to lower levels of circulating AGE and to improved insulin sensitivity in db/db mice.
Similar articles
-
Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake.Diabetes. 2005 Aug;54(8):2314-9. doi: 10.2337/diabetes.54.8.2314. Diabetes. 2005. PMID: 16046296
-
Endogenous advanced glycation end products in pancreatic islets after short-term carbohydrate intervention in obese, diabetes-prone mice.Nutr Diabetes. 2019 Mar 11;9(1):9. doi: 10.1038/s41387-019-0077-x. Nutr Diabetes. 2019. PMID: 30858378 Free PMC article.
-
The LepRdb/db mice model for studying glycation in the context of diabetes.Diabetes Metab Res Rev. 2019 Feb;35(2):e3103. doi: 10.1002/dmrr.3103. Epub 2019 Jan 7. Diabetes Metab Res Rev. 2019. PMID: 30467969
-
Advanced-glycation end products in insulin-resistant states.Curr Hypertens Rep. 2005 Apr;7(2):96-102. doi: 10.1007/s11906-005-0081-5. Curr Hypertens Rep. 2005. PMID: 15748532 Review.
-
Glycation and Hypoxia: Two Key Factors for Adipose Tissue Dysfunction.Curr Med Chem. 2015;22(20):2417-37. doi: 10.2174/0929867322666150209155633. Curr Med Chem. 2015. PMID: 25666792 Review.
Cited by
-
Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.Am J Pathol. 2009 Oct;175(4):1722-32. doi: 10.2353/ajpath.2009.090138. Epub 2009 Sep 24. Am J Pathol. 2009. PMID: 19779136 Free PMC article.
-
Glycoxidation and diabetic complications: modern lessons and a warning?Rev Endocr Metab Disord. 2004 Aug;5(3):181-8. doi: 10.1023/B:REMD.0000032406.84813.f6. Rev Endocr Metab Disord. 2004. PMID: 15211089 Review. No abstract available.
-
Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms.Mol Metab. 2013 Dec 7;3(2):94-108. doi: 10.1016/j.molmet.2013.11.006. eCollection 2014 Apr. Mol Metab. 2013. PMID: 24634815 Free PMC article. Review.
-
A Role for Advanced Glycation End Products in Molecular Ageing.Int J Mol Sci. 2023 Jun 8;24(12):9881. doi: 10.3390/ijms24129881. Int J Mol Sci. 2023. PMID: 37373042 Free PMC article. Review.
-
Methylglyoxal-induced glycation changes adipose tissue vascular architecture, flow and expansion, leading to insulin resistance.Sci Rep. 2017 May 10;7(1):1698. doi: 10.1038/s41598-017-01730-3. Sci Rep. 2017. PMID: 28490763 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous